Genscript Biotech Corp (GNNSF)
1.47
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Genscript Biotech Debt to Equity Ratio: 0.2474 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.2474 |
| June 30, 2023 | 0.2258 |
| December 31, 2022 | 0.2916 |
| June 30, 2022 | 0.2591 |
| December 31, 2021 | 0.1162 |
| June 30, 2021 | 0.0383 |
| December 31, 2020 | 0.0424 |
| June 30, 2020 | 0.0531 |
| December 31, 2019 | 0.049 |
| Date | Value |
|---|---|
| June 30, 2019 | 0.0423 |
| December 31, 2018 | 0.0219 |
| June 30, 2018 | 0.0012 |
| December 31, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| June 30, 2016 | 0.0073 |
| December 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0383
Minimum
Jun 2021
0.2916
Maximum
Dec 2022
0.1365
Average
0.0847
Median
Debt to Equity Ratio Benchmarks
| Sinovac Biotech Ltd | 0.0292 |
| CASI Pharmaceuticals Inc | 0.7819 |
| Zai Lab Ltd | 0.00 |
| I-MAB | 0.0517 |
| Gracell Biotechnologies Inc (DELISTED) | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.387B |
| Total Liabilities (Quarterly) | 1.343B |
| Shareholders Equity (Quarterly) | 1.391B |
| Current Ratio | 4.756 |
| Net Debt Paydown Yield | -0.95% |